Compare Expedia Group Inc (EXPE) vs Herbalife Nutrition Ltd (HLF) Price & Performance

Expedia Group (EXPE) trades at $264.76, down 0.57% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with revenue growth to $14.73B in 2025 and consistent earnings beats, including Q1 2026 EPS of $1.96 versus $1.41 expected. Recent developments include a strategic partnership with Allegiant Travel and positive analyst coverage highlighting growth potential. Valuation metrics include a P/E of 23.6 and P/S of 2.29, indicating reasonable pricing relative to peers.

The outlook for EXPE is positive, driven by robust travel demand, strategic initiatives, and a consensus price target of $292.09 implying ~10% upside. Key risks include macroeconomic sensitivity affecting travel spending and competitive pressures. Institutional sentiment is bullish with 45% buy ratings, though investors should monitor execution on growth targets and industry cyclicality.

HLF trades at $12.45, up 1.72% today, with a bearish technical signal from moving averages. The company shows stable revenue around $5B annually, with a net income margin of 4.66% in 2025. Recent Q1 2026 earnings beat expectations, and the company raised full-year guidance. Positive news includes inclusion in TIME's America's Best Companies 2026 and a major debt refinancing, though insider selling and negative shareholder equity present concerns.

The outlook is mixed: strong brand recognition and earnings beats support upside, but high debt levels and bearish technicals pose risks. Analyst consensus is bullish with 57.7% buy ratings, yet the stock faces headwinds from competitive pressures and reliance on international growth markets like India.